查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1422916

2024-2032 年按类型、年龄层、配销通路、应用、最终用途和地区分類的黏稠补充剂市场

Viscosupplementation Market by Type, Age Group, Distribution Channel, Application, End Use, and Region 2024-2032
出版日期: | 出版商: IMARC | 英文 149 Pages | 商品交期: 2-3个工作天内

价格

2023年全球黏稠补充剂市场规模达到45亿美元。展望未来， IMARC Group预计到2032年市场规模将达到87亿美元，2024-2032年复合年增长率（CAGR）为7.42%。骨质疏鬆症和骨关节炎（OA）盛行率的增加以及消费者对微创非手术治疗的倾向的转变是推动市场发展的一些关键因素。

黏性补充代表一种微创医疗程序，其中将包含被称为外源性液压酸（HA）衍生物的凝胶状流体的关节内注射直接施用到患者的膝关节中。它充当润滑剂，使骨骼能够在彼此之间平滑移动，减少炎症，并充当关节负荷的减震器。黏液补充可减少运动过程中的摩擦，帮助滑液产生更多缓衝，消除剧烈疼痛，并增强关节的运动或活动范围。除此之外，它还能恢復滑液的流变特性，进而产生机械、镇痛、抗发炎和软骨保护作用。因此，黏弹性补充被广泛用于治疗膝关节、髋部和手骨关节炎。目前主要有中、低、高分子量。

粘稠补充剂市场趋势：

骨质疏鬆症和骨关节炎（OA）盛行率的增加是推动市场成长的关键因素之一。与此一致的是，消费者对微创非手术治疗方案的倾向不断变化，促进了医疗保健领域广泛采用黏弹性补充剂来治疗皮质类固醇和关节疼痛。反过来，这也是另一个主要的成长诱导因素。消费者对非手术治疗的多重好处的认识不断增强，包括无需住院、费用更少、并发症最少以及更好的临床结果和康復率，进一步影响了这一点。此外，政府的有利措施和各製药公司为推出新药和不同给药途径而进行的大量投资正在支持市场成长。此外，门诊手术中心（ACS）的出现，提供强化治疗，解决身体各部位（如关节、韧带、肌肉、脊椎和神经）的手术和非手术问题，有利于市场成长。此外，开放标籤单注射液压酸的推出正在推动市场成长。除此之外，有利的医疗保险报销政策、易患慢性疾病的老年人口不断增加、慢性残疾人数不断增加、主要参与者之间的合作和伙伴关係以及该领域持续的研发活动医学科学的发展对市场成长产生正面影响。

本报告回答的关键问题：

  • 迄今为止，全球黏稠补充剂市场表现如何，未来几年将如何表现？
  • 全球黏稠补充剂市场的驱动因素、限制因素和机会是什么？
  • 主要区域市场有哪些？
  • 哪些国家代表了最具吸引力的黏稠补充市场？
  • 依类型划分市场是怎么样的？
  • 市场按年龄层划分是怎样的？
  • 基于配销通路的市场区隔是什么？
  • 基于应用程式的市场区隔是什么？
  • 根据最终用途分類的市场是怎样的？
  • 全球黏稠补充剂市场的竞争结构如何？
  • 谁是全球黏稠补充剂市场的主要参与者/公司？

目录

第一章：前言

第 2 章：范围与方法

  • 研究目的
  • 利害关係人
  • 资料来源
    • 主要资源
    • 二手资料
  • 市场预测
    • 自下而上的方法
    • 自上而下的方法
  • 预测方法

第 3 章：执行摘要

第 4 章：简介

  • 概述
  • 主要行业趋势

第 5 章：全球黏稠补充剂市场

  • 市场概况
  • 市场业绩
  • COVID-19 的影响
  • 市场预测

第 6 章：市场区隔：按类型

  • 单次注射
    • 市场走向
    • 市场预测
  • 三注射
    • 市场走向
    • 市场预测
  • 五注射
    • 市场走向
    • 市场预测

第 7 章：市场区隔：依年龄段

  • 成年人
    • 市场走向
    • 市场预测
  • 老年医学
    • 市场走向
    • 市场预测

第 8 章：市场区隔：按配销通路

  • 医院药房
    • 市场走向
    • 市场预测
  • 零售药局
    • 市场走向
    • 市场预测
  • 网路药局
    • 市场走向
    • 市场预测

第 9 章：市场区隔：按应用

  • 膝骨关节炎
    • 市场走向
    • 市场预测
  • 髋骨关节炎
    • 市场走向
    • 市场预测
  • 手部骨关节炎
    • 市场走向
    • 市场预测
  • 其他的
    • 市场走向
    • 市场预测

第 10 章：市场区隔：最终用途别

  • 医院
    • 市场走向
    • 市场预测
  • 骨科诊所
    • 市场走向
    • 市场预测
  • 其他的
    • 市场走向
    • 市场预测

第 11 章：市场区隔：按地区

  • 北美洲
    • 美国
      • 市场走向
      • 市场预测
    • 加拿大
      • 市场走向
      • 市场预测
  • 亚太
    • 中国
      • 市场走向
      • 市场预测
    • 日本
      • 市场走向
      • 市场预测
    • 印度
      • 市场走向
      • 市场预测
    • 韩国
      • 市场走向
      • 市场预测
    • 澳洲
      • 市场走向
      • 市场预测
    • 印尼
      • 市场走向
      • 市场预测
    • 其他的
      • 市场走向
      • 市场预测
  • 欧洲
    • 德国
      • 市场走向
      • 市场预测
    • 法国
      • 市场走向
      • 市场预测
    • 英国
      • 市场走向
      • 市场预测
    • 义大利
      • 市场走向
      • 市场预测
    • 西班牙
      • 市场走向
      • 市场预测
    • 俄罗斯
      • 市场走向
      • 市场预测
    • 其他的
      • 市场走向
      • 市场预测
  • 拉丁美洲
    • 巴西
      • 市场走向
      • 市场预测
    • 墨西哥
      • 市场走向
      • 市场预测
    • 其他的
      • 市场走向
      • 市场预测
  • 中东和非洲
    • 市场走向
    • 市场细分：按国家/地区
    • 市场预测

第 12 章：驱动因素、限制与机会

  • 概述
  • 司机
  • 限制
  • 机会

第 13 章：价值链分析

第 14 章：波特五力分析

  • 概述
  • 买家的议价能力
  • 供应商的议价能力
  • 竞争程度
  • 新进入者的威胁
  • 替代品的威胁

第 15 章：价格分析

第16章：竞争格局

  • 市场结构
  • 关键参与者
  • 关键参与者简介
    • Anika Therapeutics Inc.
    • Aptissen SA
    • Bioventus LLC
    • Ferring Pharmaceuticals
    • Fidia Farmaceutici SpA
    • Johnson & Johnson
    • LG Chem Ltd.
    • OrthogenRx Inc. (Avanos Medical Inc.)
    • Sanofi SA
    • Seikagaku Corporation
    • Virchow Biotech Private Limited
    • Zimmer Biomet
    • Zuventus HealthCare Ltd. (Emcure Pharmaceuticals Limited)
Product Code: SR112024A6931

Abstract

The global viscosupplementation market size reached US$ 4.5 Billion in 2023. Looking forward, IMARC Group expects the market to reach US$ 8.7 Billion by 2032, exhibiting a growth rate (CAGR) of 7.42% during 2024-2032. The increasing prevalence of osteoporosis and osteoarthritis (OA) and the shifting consumer inclination toward minimally invasive non-surgical treatments represent some of the key factors driving the market.

Viscosupplementation represents a minimally invasive medical procedure wherein intraarticular injection comprising gel-like fluid known as exogenous hydraulic acid (HA) derivatives are directly administered into the knee joints of the patient. It acts as a lubricant, which enables bones to move smoothly over each other, lowers inflammation, and performs as a shock absorber for joint loads. Viscosupplementation reduces the friction during the movements, assists the synovial fluids in creating more cushion, eliminates severe pain, and enhances the range of movements or motions of the joint. Apart from this, it restores the rheological properties of the synovial fluids, which produce mechanical, analgesic, anti-inflammatory, and chondroprotective effects. As a result, viscosupplementation is extensively utilized in the treatment of knee, hip, and hand osteoarthritis. Currently, it is mainly available in intermediate, low, and high molecular weights.

Viscosupplementation Market Trends:

The increasing prevalence of osteoporosis and osteoarthritis (OA) represents one of the key factors driving the market growth. In line with this, the shifting consumer inclination toward the minimally invasive non-surgical treatment options has facilitated the widespread adoption of viscosupplementation in the healthcare sector for corticosteroids and joint pain management. This, in turn, is acting as another major growth-inducing factor. This is further influenced by the growing consumer awareness regarding the multiple benefits of non-surgical treatments, including no hospitalization, fewer expenses, minimal complications, and better clinical outcomes and recovery rates. Additionally, the favorable government initiatives and significant investments by various pharmaceutical companies to launch novel drugs and different routes of administrations is supporting the market growth. Moreover, the emergence of ambulatory surgical centers (ACS) that offer intensive treatment to resolve surgical and non-surgical problems in various body parts, such as joints, ligaments, muscle, spine, and nerves, is favoring the market growth. Furthermore, the introduction of open-label single-injections with hydraulic acid is propelling the market growth. Apart from this, favorable health insurance reimbursement policies, the rising geriatric population, which is susceptible to chronic ailments, increasing number of individuals with chronic disability, collaborations and partnership among the key players, and continuous research and development (R&D) activities in the field of medical sciences are positively impacting the market growth.

Key Market Segmentation:

IMARC Group provides an analysis of the key trends in each segment of the global viscosupplementation market, along with forecasts at the global, regional, and country level from 2024-2032. Our report has categorized the market based on type, age group, distribution channel, application and end use.

Type Insights:

Single Injection

Three Injection

Five Injection

The report has also provided a detailed breakup and analysis of viscosupplementation market based on the type. This includes single, three and five injection. According to the report, single injection represented the largest segment.

Age Group Insights:

Adults

Geriatrics

A detailed breakup and analysis of the viscosupplementation market based on the age group has also been provided in the report. This includes adults and geriatric. According to the report, geriatrics accounted for the largest market share.

Distribution Channel Insights:

Hospital Pharmacies

Retail Pharmacies

Online Pharmacies

The report has also provided a detailed breakup and analysis of viscosupplementation market based on the distribution channel. This includes hospital, retail and online pharmacies. According to the report, hospital pharmacies represented the largest segment.

Application Insights:

Knee Osteoarthritis

Hip Osteoarthritis

Hand Osteoarthritis

Others

A detailed breakup and analysis of the viscosupplementation market based on the application has also been provided in the report. This includes knee, hip and hand osteoarthritis. According to the report, knee osteoarthritis accounted for the largest market share.

End Use Insights:

Hospitals

Orthopedic Clinics

Others

The report has also provided a detailed breakup and analysis of viscosupplementation market based on the end use. This includes hospitals, orthopedic clinics, and others. According to the report, orthopedic clinics represented the largest segment.

Regional Insights:

North America

United States

Canada

Asia Pacific

China

Japan

India

South Korea

Australia

Indonesia

Others

Europe

Germany

France

United Kingdom

Italy

Spain

Russia

Others

Latin America

Brazil

Mexico

Others

Middle East and Africa

The report has also provided a comprehensive analysis of all the major regional markets that include North America (the United States and Canada); Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, and others); Europe (Germany, France, the United Kingdom, Italy, Spain, Russia, and others); Latin America (Brazil, Mexico, and others); and the Middle East and Africa. According to the report, the North America was the largest market for viscosupplementation. Some of the factors driving the North America viscosupplementation market included the rising geriatric population and the affordable health insurance reimbursement policies.

Competitive Landscape:

The report has also provided a comprehensive analysis of the competitive landscape in the global viscosupplementation market. Detailed profiles of all major companies have also been provided. Some of the companies covered include Anika Therapeutics Inc., Aptissen S.A., Bioventus LLC, Ferring Pharmaceuticals, Fidia Farmaceutici S.p.A., Johnson & Johnson, LG Chem Ltd., OrthogenRx Inc. (Avanos Medical Inc.), Sanofi S.A., Seikagaku Corporation, Virchow Biotech Private Limited, Zimmer Biomet, Zuventus HealthCare Ltd. (Emcure Pharmaceuticals Limited), etc.

Key Questions Answered in This Report:

  • How has the global viscosupplementation market performed so far and how will it perform in the coming years?
  • What are the drivers, restraints, and opportunities in the global viscosupplementation market?
  • What are the key regional markets?
  • Which countries represent the most attractive viscosupplementation markets?
  • What is the breakup of the market based on the type?
  • What is the breakup of the market based on the age group?
  • What is the breakup of the market based on the distribution channel?
  • What is the breakup of the market based on the application?
  • What is the breakup of the market based on the end use?
  • What is the competitive structure of the global viscosupplementation market?
  • Who are the key players/companies in the global viscosupplementation market?

Table of Contents

1 Preface

2 Scope and Methodology

  • 2.1 Objectives of the Study
  • 2.2 Stakeholders
  • 2.3 Data Sources
    • 2.3.1 Primary Sources
    • 2.3.2 Secondary Sources
  • 2.4 Market Estimation
    • 2.4.1 Bottom-Up Approach
    • 2.4.2 Top-Down Approach
  • 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

  • 4.1 Overview
  • 4.2 Key Industry Trends

5 Global Viscosupplementation Market

  • 5.1 Market Overview
  • 5.2 Market Performance
  • 5.3 Impact of COVID-19
  • 5.4 Market Forecast

6 Market Breakup by Type

  • 6.1 Single Injection
    • 6.1.1 Market Trends
    • 6.1.2 Market Forecast
  • 6.2 Three Injection
    • 6.2.1 Market Trends
    • 6.2.2 Market Forecast
  • 6.3 Five Injection
    • 6.3.1 Market Trends
    • 6.3.2 Market Forecast

7 Market Breakup by Age Group

  • 7.1 Adults
    • 7.1.1 Market Trends
    • 7.1.2 Market Forecast
  • 7.2 Geriatrics
    • 7.2.1 Market Trends
    • 7.2.2 Market Forecast

8 Market Breakup by Distribution Channel

  • 8.1 Hospital Pharmacies
    • 8.1.1 Market Trends
    • 8.1.2 Market Forecast
  • 8.2 Retail Pharmacies
    • 8.2.1 Market Trends
    • 8.2.2 Market Forecast
  • 8.3 Online Pharmacies
    • 8.3.1 Market Trends
    • 8.3.2 Market Forecast

9 Market Breakup by Application

  • 9.1 Knee Osteoarthritis
    • 9.1.1 Market Trends
    • 9.1.2 Market Forecast
  • 9.2 Hip Osteoarthritis
    • 9.2.1 Market Trends
    • 9.2.2 Market Forecast
  • 9.3 Hand Osteoarthritis
    • 9.3.1 Market Trends
    • 9.3.2 Market Forecast
  • 9.4 Others
    • 9.4.1 Market Trends
    • 9.4.2 Market Forecast

10 Market Breakup by End Use

  • 10.1 Hospitals
    • 10.1.1 Market Trends
    • 10.1.2 Market Forecast
  • 10.2 Orthopedic Clinics
    • 10.2.1 Market Trends
    • 10.2.2 Market Forecast
  • 10.3 Others
    • 10.3.1 Market Trends
    • 10.3.2 Market Forecast

11 Market Breakup by Region

  • 11.1 North America
    • 11.1.1 United States
      • 11.1.1.1 Market Trends
      • 11.1.1.2 Market Forecast
    • 11.1.2 Canada
      • 11.1.2.1 Market Trends
      • 11.1.2.2 Market Forecast
  • 11.2 Asia-Pacific
    • 11.2.1 China
      • 11.2.1.1 Market Trends
      • 11.2.1.2 Market Forecast
    • 11.2.2 Japan
      • 11.2.2.1 Market Trends
      • 11.2.2.2 Market Forecast
    • 11.2.3 India
      • 11.2.3.1 Market Trends
      • 11.2.3.2 Market Forecast
    • 11.2.4 South Korea
      • 11.2.4.1 Market Trends
      • 11.2.4.2 Market Forecast
    • 11.2.5 Australia
      • 11.2.5.1 Market Trends
      • 11.2.5.2 Market Forecast
    • 11.2.6 Indonesia
      • 11.2.6.1 Market Trends
      • 11.2.6.2 Market Forecast
    • 11.2.7 Others
      • 11.2.7.1 Market Trends
      • 11.2.7.2 Market Forecast
  • 11.3 Europe
    • 11.3.1 Germany
      • 11.3.1.1 Market Trends
      • 11.3.1.2 Market Forecast
    • 11.3.2 France
      • 11.3.2.1 Market Trends
      • 11.3.2.2 Market Forecast
    • 11.3.3 United Kingdom
      • 11.3.3.1 Market Trends
      • 11.3.3.2 Market Forecast
    • 11.3.4 Italy
      • 11.3.4.1 Market Trends
      • 11.3.4.2 Market Forecast
    • 11.3.5 Spain
      • 11.3.5.1 Market Trends
      • 11.3.5.2 Market Forecast
    • 11.3.6 Russia
      • 11.3.6.1 Market Trends
      • 11.3.6.2 Market Forecast
    • 11.3.7 Others
      • 11.3.7.1 Market Trends
      • 11.3.7.2 Market Forecast
  • 11.4 Latin America
    • 11.4.1 Brazil
      • 11.4.1.1 Market Trends
      • 11.4.1.2 Market Forecast
    • 11.4.2 Mexico
      • 11.4.2.1 Market Trends
      • 11.4.2.2 Market Forecast
    • 11.4.3 Others
      • 11.4.3.1 Market Trends
      • 11.4.3.2 Market Forecast
  • 11.5 Middle East and Africa
    • 11.5.1 Market Trends
    • 11.5.2 Market Breakup by Country
    • 11.5.3 Market Forecast

12 Drivers, Restraints, and Opportunities

  • 12.1 Overview
  • 12.2 Drivers
  • 12.3 Restraints
  • 12.4 Opportunities

13 Value Chain Analysis

14 Porters Five Forces Analysis

  • 14.1 Overview
  • 14.2 Bargaining Power of Buyers
  • 14.3 Bargaining Power of Suppliers
  • 14.4 Degree of Competition
  • 14.5 Threat of New Entrants
  • 14.6 Threat of Substitutes

15 Price Analysis

16 Competitive Landscape

  • 16.1 Market Structure
  • 16.2 Key Players
  • 16.3 Profiles of Key Players
    • 16.3.1 Anika Therapeutics Inc.
      • 16.3.1.1 Company Overview
      • 16.3.1.2 Product Portfolio
      • 16.3.1.3 Financials
      • 16.3.1.4 SWOT Analysis
    • 16.3.2 Aptissen S.A.
      • 16.3.2.1 Company Overview
      • 16.3.2.2 Product Portfolio
    • 16.3.3 Bioventus LLC
      • 16.3.3.1 Company Overview
      • 16.3.3.2 Product Portfolio
      • 16.3.3.3 Financials
    • 16.3.4 Ferring Pharmaceuticals
      • 16.3.4.1 Company Overview
      • 16.3.4.2 Product Portfolio
    • 16.3.5 Fidia Farmaceutici S.p.A.
      • 16.3.5.1 Company Overview
      • 16.3.5.2 Product Portfolio
    • 16.3.6 Johnson & Johnson
      • 16.3.6.1 Company Overview
      • 16.3.6.2 Product Portfolio
      • 16.3.6.3 Financials
      • 16.3.6.4 SWOT Analysis
    • 16.3.7 LG Chem Ltd.
      • 16.3.7.1 Company Overview
      • 16.3.7.2 Product Portfolio
      • 16.3.7.3 Financials
      • 16.3.7.4 SWOT Analysis
    • 16.3.8 OrthogenRx Inc. (Avanos Medical Inc.)
      • 16.3.8.1 Company Overview
      • 16.3.8.2 Product Portfolio
    • 16.3.9 Sanofi S.A.
      • 16.3.9.1 Company Overview
      • 16.3.9.2 Product Portfolio
      • 16.3.9.3 Financials
      • 16.3.9.4 SWOT Analysis
    • 16.3.10 Seikagaku Corporation
      • 16.3.10.1 Company Overview
      • 16.3.10.2 Product Portfolio
      • 16.3.10.3 Financials
    • 16.3.11 Virchow Biotech Private Limited
      • 16.3.11.1 Company Overview
      • 16.3.11.2 Product Portfolio
    • 16.3.12 Zimmer Biomet
      • 16.3.12.1 Company Overview
      • 16.3.12.2 Product Portfolio
      • 16.3.12.3 Financials
      • 16.3.12.4 SWOT Analysis
    • 16.3.13 Zuventus HealthCare Ltd. (Emcure Pharmaceuticals Limited)
      • 16.3.13.1 Company Overview
      • 16.3.13.2 Product Portfolio

List of Figures

  • Figure 1: Global: Viscosupplementation Market: Major Drivers and Challenges
  • Figure 2: Global: Viscosupplementation Market: Sales Value (in Billion US$), 2018-2023
  • Figure 3: Global: Viscosupplementation Market Forecast: Sales Value (in Billion US$), 2024-2032
  • Figure 4: Global: Viscosupplementation Market: Breakup by Type (in %), 2023
  • Figure 5: Global: Viscosupplementation Market: Breakup by Age Group (in %), 2023
  • Figure 6: Global: Viscosupplementation Market: Breakup by Distribution Channel (in %), 2023
  • Figure 7: Global: Viscosupplementation Market: Breakup by Application (in %), 2023
  • Figure 8: Global: Viscosupplementation Market: Breakup by End Use (in %), 2023
  • Figure 9: Global: Viscosupplementation Market: Breakup by Region (in %), 2023
  • Figure 10: Global: Viscosupplementation (Single Injection) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 11: Global: Viscosupplementation (Single Injection) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 12: Global: Viscosupplementation (Three Injection) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 13: Global: Viscosupplementation (Three Injection) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 14: Global: Viscosupplementation (Five Injection) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 15: Global: Viscosupplementation (Five Injection) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 16: Global: Viscosupplementation (Adults) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 17: Global: Viscosupplementation (Adults) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 18: Global: Viscosupplementation (Geriatrics) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 19: Global: Viscosupplementation (Geriatrics) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 20: Global: Viscosupplementation (Hospital Pharmacies) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 21: Global: Viscosupplementation (Hospital Pharmacies) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 22: Global: Viscosupplementation (Retail Pharmacies) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 23: Global: Viscosupplementation (Retail Pharmacies) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 24: Global: Viscosupplementation (Online Pharmacies) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 25: Global: Viscosupplementation (Online Pharmacies) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 26: Global: Viscosupplementation (Knee Osteoarthritis) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 27: Global: Viscosupplementation (Knee Osteoarthritis) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 28: Global: Viscosupplementation (Hip Osteoarthritis) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 29: Global: Viscosupplementation (Hip Osteoarthritis) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 30: Global: Viscosupplementation (Hand Osteoarthritis) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 31: Global: Viscosupplementation (Hand Osteoarthritis) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 32: Global: Viscosupplementation (Other Applications) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 33: Global: Viscosupplementation (Other Applications) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 34: Global: Viscosupplementation (Hospitals) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 35: Global: Viscosupplementation (Hospitals) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 36: Global: Viscosupplementation (Orthopedic Clinics) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 37: Global: Viscosupplementation (Orthopedic Clinics) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 38: Global: Viscosupplementation (Other End Uses) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 39: Global: Viscosupplementation (Other End Uses) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 40: North America: Viscosupplementation Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 41: North America: Viscosupplementation Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 42: United States: Viscosupplementation Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 43: United States: Viscosupplementation Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 44: Canada: Viscosupplementation Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 45: Canada: Viscosupplementation Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 46: Asia-Pacific: Viscosupplementation Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 47: Asia-Pacific: Viscosupplementation Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 48: China: Viscosupplementation Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 49: China: Viscosupplementation Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 50: Japan: Viscosupplementation Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 51: Japan: Viscosupplementation Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 52: India: Viscosupplementation Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 53: India: Viscosupplementation Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 54: South Korea: Viscosupplementation Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 55: South Korea: Viscosupplementation Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 56: Australia: Viscosupplementation Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 57: Australia: Viscosupplementation Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 58: Indonesia: Viscosupplementation Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 59: Indonesia: Viscosupplementation Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 60: Others: Viscosupplementation Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 61: Others: Viscosupplementation Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 62: Europe: Viscosupplementation Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 63: Europe: Viscosupplementation Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 64: Germany: Viscosupplementation Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 65: Germany: Viscosupplementation Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 66: France: Viscosupplementation Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 67: France: Viscosupplementation Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 68: United Kingdom: Viscosupplementation Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 69: United Kingdom: Viscosupplementation Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 70: Italy: Viscosupplementation Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 71: Italy: Viscosupplementation Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 72: Spain: Viscosupplementation Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 73: Spain: Viscosupplementation Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 74: Russia: Viscosupplementation Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 75: Russia: Viscosupplementation Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 76: Others: Viscosupplementation Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 77: Others: Viscosupplementation Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 78: Latin America: Viscosupplementation Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 79: Latin America: Viscosupplementation Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 80: Brazil: Viscosupplementation Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 81: Brazil: Viscosupplementation Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 82: Mexico: Viscosupplementation Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 83: Mexico: Viscosupplementation Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 84: Others: Viscosupplementation Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 85: Others: Viscosupplementation Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 86: Middle East and Africa: Viscosupplementation Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 87: Middle East and Africa: Viscosupplementation Market: Breakup by Country (in %), 2023
  • Figure 88: Middle East and Africa: Viscosupplementation Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 89: Global: Viscosupplementation Industry: Drivers, Restraints, and Opportunities
  • Figure 90: Global: Viscosupplementation Industry: Value Chain Analysis
  • Figure 91: Global: Viscosupplementation Industry: Porter's Five Forces Analysis

List of Tables

  • Table 1: Global: Viscosupplementation Market: Key Industry Highlights, 2023 & 2032
  • Table 2: Global: Viscosupplementation Market Forecast: Breakup by Type (in Million US$), 2024-2032
  • Table 3: Global: Viscosupplementation Market Forecast: Breakup by Age Group (in Million US$), 2024-2032
  • Table 4: Global: Viscosupplementation Market Forecast: Breakup by Distribution Channel (in Million US$), 2024-2032
  • Table 5: Global: Viscosupplementation Market Forecast: Breakup by Application (in Million US$), 2024-2032
  • Table 6: Global: Viscosupplementation Market Forecast: Breakup by End Use (in Million US$), 2024-2032
  • Table 7: Global: Viscosupplementation Market Forecast: Breakup by Region (in Million US$), 2024-2032
  • Table 8: Global: Viscosupplementation Market: Competitive Structure
  • Table 9: Global: Viscosupplementation Market: Key Players